Search for: "GERMANY v. WYETH"
Results 1 - 20
of 34
Sorted by Relevance
|
Sort by Date
9 Aug 2019, 2:59 am
What made Germany different? [read post]
21 Mar 2012, 3:12 am
” Tags: medical, patent law, Supreme Court Related posts “Process patents” at the Supreme Court (0) Wyeth v. [read post]
27 Feb 2012, 4:32 am
Can’t Be the World’s Court” (0) Wyeth v. [read post]
15 Nov 2009, 9:04 pm
Tags: alcohol, banana pesticide litigation fraud, Dickie Scruggs, Erin Brockovich, FDA, federalism, Federalist Society, Germany, India, preemption, Thomas Girardi, Wikipedia Related posts Wyeth v. [read post]
5 Dec 2008, 1:00 pm
You can separately subscribe to the Pharma & Biotech Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: European Commission issues preliminary report on its inquiry into competition in the pharmaceutical sector (IPKat) (Copyfight) (IAM) (Managing Intellectual Property) (Law360) (Patent Docs)… [read post]
23 Jun 2010, 10:28 pm
(Patent Docs) Cydectin (Moxidectin - US: CAFC decision regarding when testing phase ends and approval phase begins for NADA in PTE case Wyeth Holdings Corp. v. [read post]
12 Nov 2009, 10:10 pm
Instead, the court held that the issue was controlled by the Supreme Court's recent decision in Wyeth v. [read post]
17 Apr 2009, 12:00 am
Eli Lilly invalid (Patent Baristas), (Law 360) (Patent Docs) General Blockbusters and other strategies (IP Think Tank) AU - TRIPS, Pharmaceuticals and Manufacture for Export - IP Think Tank Podcast (IP Think Tank) Germany: Open fight on biotechnology, patents, and CIIs (IP Jur) US - It’s not an invention if you use conventional techniques to make it (Patent Baristas) US - Debate on creating a regulatory pathway for approval of follow-on biologics (FOB) (Patent Baristas)… [read post]
31 Jan 2010, 12:21 pm
USPTO’s interim procedures for patent term extensions: Last week the AmeriKat reported on the important decision of Wyeth v Kappos which held that the USPTO misapplied patent term calculations resulting in shorter patent terms for patentees than what they should have been. [read post]
23 Dec 2020, 5:31 am
This UK roundup adds the final chapter in the IPKat's 4-part series of round-ups from the Netherlands, Germany and France earlier this year. [read post]
25 Jan 2011, 10:58 pm
General GSK critiques Anti-Counterfeiting Trade Agreement (IP Watch) WHO Members show dismay at delay on Counterfeit Medicines Group (IP Watch) WHO R&D financing committee approved with controversial industry expert (IP Watch) (KEI) (KEI) (KEI) BioCentury this week explores orphan drugs with HP&M attorney and NORD Board Chair (FDA Law Blog) EU: Paediatric extensions and transitional provisions: a question of timing (The SPC Blog) India: Patent Office continue refusing pharmaceutical… [read post]
17 May 2021, 12:45 am
In its statement of answer, Wyeth indicated that it would primarily rely on its second auxiliary request, and would not defend the claims as granted. [read post]
8 Dec 2016, 3:20 am
G7/832) What was unusual about the composition of the English Patents Court in the John Wyeth case in 1985? [read post]
18 May 2011, 12:33 am
COPEGUS (Class 46) Effexor (Venlafaxine) – US: Wyeth files patent infringement suit against Nostrum in response to Para IV challenge (Patent Docs) Escitalopram – Germany: Escitalopram revisited – Federal Patent Court rules in favor of validity of SPC for enantiomer over earlier marketing authorization for racemate (Kluwer Patent Blog) Fluticasone – US: Perrigo to settle all Hatch-Waxman litigation relating to Fluticasone lotion (GenericsWeb) Focalin… [read post]
22 May 2014, 5:00 am
As one might expect, particularly since the Agency has been criticized as lacking sufficient resources to do its job, e.g., Wyeth v. [read post]
17 Jan 2012, 11:24 am
Wyeth, Inc., 168 Cal. [read post]
1 Nov 2010, 2:46 am
& Anor v. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
16 Nov 2007, 4:00 am
Justice Michel Bastarache, of the Supreme Court of Canada, criticized that court for the 2004 decisions in the Monsanto Canada Inc. v. [read post]
20 Jun 2008, 8:07 am
– Marks & Clerk Biotechnology Report 2008: (IP finance), Pfizer and Daiichi-Sankyo’s bidding for Ranbaxy: (IP ThinkTank), (IAM), (Managing Intellectual Property), (GenericsWeb), Cutting Edge Information study reveals 53% of pharma patents approach expiration before litigation strategies are implemented: (Peter Zura's 271 Patent Blog), Quanta and agricultural biotechnology: (Holman’s Biotech IP Blog), Breakthough by WHO will give poor countries better access… [read post]
